Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity Post author:Sam Post published:July 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Grants Merck's Keytruda Priority Review for Cervical Cancer March 12, 2018 <b>Repare Therapeutics</b> Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums June 21, 2017 Sanofi's Rumored Buyout Target Flexion Shows Off Mid-Stage Osteoarthritis Data June 11, 2017
<b>Repare Therapeutics</b> Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums June 21, 2017